Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
100.15
+1.32 (1.34%)
Sep 22, 2026, 2:23 PM EDT - Market open
Rhythm Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 17, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 16, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $155 | Buy | Maintains | $155 | +54.77% | Sep 15, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $133 | Buy | Initiates | $133 | +32.80% | Sep 14, 2026 |
| Deutsche Bank | Deutsche Bank | Hold Initiates $120 | Hold | Initiates | $120 | +19.82% | Aug 28, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $150 | Buy | Reiterates | $150 | +49.78% | Aug 25, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $143 | Buy | Reiterates | $143 | +42.79% | Aug 25, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $151 → $154 | Buy | Maintains | $151 → $154 | +53.77% | Aug 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.